Sangeeta N. Bhatia is Director at VERTEX PHARMACEUTICALS INC / MA (VRTX). They have made 16 open-market trades across 1 company since 2017, most recently 2026-05-04.
CIK 0001643921
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 16 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| VRTX | 4,924 | $2.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VRTX | SELL · 10b5-1 | 2026-05-04 | 2026-05-05 | $423.73 | $135K | +2.6% | +3.7% | +10.4% |
| VRTX | SELL · 10b5-1 | 2026-02-13 | 2026-02-18 | $500.00 | $133K | +3.4% | -3.4% | -7.6% |
| VRTX | SELL · 10b5-1 | 2025-08-27 | 2025-08-29 | $386.69 | $206K | +1.6% | +1.1% | +10.9% |
| VRTX | SELL · 10b5-1 | 2025-05-02 | 2025-05-05 | $505.86 | $202K | -6.7% | -4.2% | +1.4% |
| VRTX | SELL · 10b5-1 | 2024-08-30 | 2024-09-04 | $500.00 | $323K | +2.4% | -4.7% | -4.3% |
| VRTX | SELL · 10b5-1 | 2024-08-08 | 2024-08-12 | $466.29 | $1.2M | +3.5% | +2.4% | +8.2% |
| VRTX | SELL · 10b5-1 | 2024-05-02 | 2024-05-03 | $402.95 | $376K | +8.6% | +16.7% | +25.6% |
| VRTX | SELL · 10b5-1 | 2023-10-17 | 2023-10-19 | $375.00 | $91K | -1.0% | -2.4% | +18.6% |
| VRTX | SELL · 10b5-1 | 2023-10-06 | 2023-10-11 | $360.00 | $87K | +0.4% | +2.0% | +14.9% |
| VRTX | SELL · 10b5-1 | 2023-08-09 | 2023-08-11 | $345.51 | $167K | +0.5% | -0.4% | +5.7% |
| VRTX | SELL · 10b5-1 | 2023-05-02 | 2023-05-03 | $348.26 | $319K | +0.2% | -4.1% | -0.1% |
| VRTX | SELL | 2022-10-24 | 2022-10-26 | $310.00 | $193K | -2.4% | +0.7% | +0.9% |
| VRTX | SELL | 2022-08-08 | 2022-08-10 | $293.06 | $242K | -0.5% | -1.1% | +3.8% |
| VRTX | SELL | 2022-07-29 | 2022-08-02 | $278.77 | $173K | +6.7% | +5.1% | +13.0% |
| VRTX | SELL | 2022-05-02 | 2022-05-04 | $258.55 | $263K | -6.4% | -0.8% | +0.8% |
| VRTX | SELL | 2022-04-08 | 2022-04-12 | $280.20 | $1.1M | -3.5% | -14.5% | +4.4% |
| VRTX | SELL | 2021-06-02 | 2021-06-04 | $209.44 | $177K | -11.0% | -5.0% | -5.4% |
| VRTX | SELL | 2020-10-05 | 2020-10-07 | $266.79 | $5.6M | -17.5% | -17.5% | -14.4% |
| VRTX | SELL | 2020-06-02 | 2020-06-03 | $283.05 | $440K | -2.4% | +6.2% | +0.4% |
| VRTX | SELL | 2019-11-01 | 2019-11-04 | $200.00 | $258K | +3.0% | +12.5% | +15.8% |
| VRTX | SELL | 2019-10-02 | 2019-10-04 | $166.80 | $2.8M | +2.6% | +16.2% | +27.9% |
| VRTX | SELL | 2019-06-03 | 2019-06-04 | $167.30 | $174K | -1.0% | +3.7% | +4.0% |
| VRTX | SELL | 2018-10-03 | 2018-10-05 | $192.13 | $1.7M | -0.8% | -6.6% | -12.4% |
| VRTX | SELL | 2018-06-04 | 2018-06-05 | $152.05 | $266K | +6.4% | +16.3% | +25.8% |
| VRTX | SELL | 2018-01-05 | 2018-01-09 | $156.00 | $1.7M | +3.8% | -2.8% | +0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.